Your body already has a built-in system for dissolving fibrin, the protein mesh that holds blood clots together. That system, called fibrinolysis, can be supported through specific enzymes, dietary choices, exercise, and stress reduction. But “getting rid of fibrin naturally” is not as simple as taking a supplement, because fibrin plays a critical role in wound healing. The real goal is keeping fibrin turnover in healthy balance so excess deposits do not linger in your bloodstream.
How Your Body Dissolves Fibrin on Its Own
When you cut yourself, fibrin forms a mesh over the wound like biological scaffolding. Once the tissue underneath heals, your body needs to tear that scaffolding down. It does this through fibrinolysis, an enzymatic process in which an inactive protein called plasminogen gets converted into plasmin, the enzyme that chews through fibrin fibers and breaks them into soluble fragments the body can clear away.1PubMed Central. Fibrin and Fibrinolytic Enzyme Cascade in Thrombosis: Unravelling the Role Two activators drive this conversion: tissue-type plasminogen activator (t-PA) and urokinase-type plasminogen activator (u-PA). Your blood vessel walls release t-PA, and fibrin itself actually enhances t-PA’s ability to work, so the mere presence of a clot accelerates the signal for its own removal.2PubMed Central. Fibrinolysis: an illustrated review
This process is not all-or-nothing. Your body also produces inhibitors that slow fibrinolysis down, preventing clots from dissolving too quickly while a wound is still healing. Plasminogen activator inhibitor-1 (PAI-1), for instance, blocks t-PA from doing its job. When these inhibitors are too active or when fibrin is produced faster than plasmin can clear it, you end up with excess fibrin in circulation. That excess is linked to higher cardiovascular risk. A large pooled analysis found that for every 1-gram-per-liter increase in circulating fibrinogen, the risk of coronary heart disease roughly doubled, and stroke risk rose by a similar magnitude.3JAMA. Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality So the question is really about keeping this system running efficiently.
Fibrinolytic Enzymes You Can Take by Mouth
Several enzyme supplements have documented fibrinolytic activity in laboratory and animal studies, and a smaller number have preliminary human data. These are sometimes grouped under the label “systemic enzymes.” They differ in where they come from, how well they survive digestion, and how much clinical evidence backs them.
Nattokinase
Nattokinase is extracted from natto, a traditional Japanese food made from fermented soybeans. It is the most studied of the natural fibrinolytic enzymes. Research has shown it has direct fibrin-dissolving activity along with blood-pressure-lowering, anti-atherosclerotic, and lipid-lowering effects.4PubMed Central. Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases It works both by directly breaking down fibrin and by boosting your body’s own production of plasmin. Most supplement labels suggest doses in the range of 2,000 to 4,000 fibrinolytic units per day, though standardized dosing from clinical trials remains limited. One important safety note: a case report documented a patient who replaced warfarin with nattokinase after a mechanical heart valve replacement and developed a blood clot on the valve within a year, eventually needing a second surgery.5PubMed Central. Consequence of patient substitution of nattokinase for warfarin after aortic valve replacement with a mechanical prosthesis Nattokinase is not a replacement for prescription anticoagulants.
Serrapeptase
Serrapeptase (also called serratiopeptidase) is a proteolytic enzyme originally isolated from the gut bacteria of silkworms. It breaks down fibrin and also thins the fluids that accumulate during inflammation, which is why it has traditionally been used for pain and swelling after surgery or in conditions like sinusitis.6PubMed Central. Serratiopeptidase: Insights into the therapeutic applications It also has anti-biofilm properties, meaning it can help break down the protective coatings that bacteria build around themselves, which has implications beyond blood clotting.7PubMed. An up-to-date review of biomedical applications of serratiopeptidase and its biobetter derivatives as a multi-potential metalloprotease The fibrinolytic evidence is mostly from lab and animal models. Human trials on its clot-dissolving ability are still sparse, though it has a longer track record in clinical use for inflammation.
Lumbrokinase
Lumbrokinase is a group of fibrinolytic enzymes extracted from earthworms. It sounds unusual, but it has a long history in traditional East Asian medicine. Lab studies confirm these enzymes degrade fibrin and are recognized as potential agents for thrombosis-related conditions.8PubMed Central. Recombinant protein production of earthworm lumbrokinase for potential antithrombotic application A key question with any oral enzyme is whether it survives the gut intact. Research using rat intestinal models found that lumbrokinase does show dose-dependent absorption through the intestinal wall, with fibrinolytic activity detectable on the other side of the gut lining.9PubMed Central. Intestinal Absorption of Fibrinolytic and Proteolytic Lumbrokinase Extracted from Earthworm, Eisenia andrei Lab experiments have also shown that a recombinant lumbrokinase protein dissolved roughly two-thirds of a blood clot when applied at high concentrations in a test tube.10PLOS ONE. Cloning, Expression and Characterization of a Gene from Earthworm Eisenia fetida Encoding a Blood-Clot Dissolving Protein Whether those in-vitro results translate to meaningful clot breakdown in a living human body at typical supplement doses remains to be established through rigorous trials.
Bromelain
Bromelain is a complex of proteolytic enzymes from pineapple. It has a broad pharmacological profile, with documented anti-inflammatory, anti-edema, and fibrinolytic activity in both lab and animal studies.11PubMed Central. Bromelain, a Group of Pineapple Proteolytic Complex Enzymes (Ananas comosus) and Their Possible Therapeutic and Clinical Effects. A Summary One lab study found that adding bromelain to blood samples reduced coagulability and inhibited platelet aggregation by about 19%, though the authors cautioned that these were test-tube results and neither oral nor intravenous dosing was evaluated.12PubMed. Bromelain has paradoxical effects on blood coagulability: a study using thromboelastography Earlier research proposed that bromelain activates plasminogen, which then generates plasmin to dissolve fibrin, and that platelets exposed to the resulting biochemical cascade become more resistant to clumping together.13Medical Hypotheses. Fibrinolytic and antithrombotic action of bromelain may eliminate thrombosis in heart patients Bromelain is among the more accessible of these enzymes since pineapple is a common food, but the concentrations used in research far exceed what you would get from eating the fruit.
Dietary Strategies That Lower Fibrinogen
Beyond supplemental enzymes, certain foods and nutrients appear to influence fibrinogen levels and fibrinolytic activity through dietary pathways rather than direct enzymatic digestion of fibrin.
Omega-3 fatty acids from fish oil are the best-studied dietary intervention. A controlled trial of 3 grams of omega-3 fish oil daily over four weeks in healthy men found that fibrinogen levels dropped by about 4%, and the effect was accompanied by reduced thrombin generation in plasma.14PubMed. Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation That may sound modest, but the researchers noted that the degree of the anticoagulant effect depended on how high fibrinogen levels were to begin with, meaning people with elevated fibrinogen could see a larger benefit. The effect occurred independently of vitamin K pathways, which is relevant because it means fish oil works through a different mechanism than warfarin and similar blood thinners.
Garlic is another dietary candidate. A study in patients with elevated blood lipids found that dried garlic supplementation significantly decreased fibrinogen and a fibrin breakdown marker called fibrinopeptide A by about 10%, while increasing the activity of plasminogen and another marker of fibrinolysis by a similar amount.15PubMed. Effect of dried garlic on blood coagulation, fibrinolysis, platelet aggregation and serum cholesterol levels in patients with hyperlipoproteinemia This suggests garlic shifts the balance in two directions at once: less fibrinogen production and more fibrin breakdown. But this was a single trial in a specific population, so the size of the effect in healthy people remains uncertain.
Exercise as a Fibrinolysis Booster
Physical activity is one of the most reliable ways to stimulate your body’s own clot-dissolving system. Exercise triggers a significant increase in fibrinolysis, mainly because it prompts the cells lining your blood vessels to release more t-PA while simultaneously reducing PAI-1, the molecule that normally blocks t-PA from working.16PubMed. Effects of exercise on blood coagulation, fibrinolysis and platelet aggregation The intensity and duration of exercise both matter: moderate to vigorous aerobic activity appears to produce a stronger fibrinolytic response than light activity.
This does not mean that a single workout permanently clears excess fibrin. The spike in t-PA and drop in PAI-1 are temporary, returning toward baseline after you stop exercising. But with regular training, the baseline levels shift favorably over time. People who exercise consistently tend to have lower resting PAI-1 and better fibrinolytic capacity at rest compared with sedentary individuals. Walking, cycling, swimming, and jogging all count. The key is consistency rather than occasional intensity.
Why Chronic Stress Makes Fibrin Harder to Clear
Stress is an underappreciated driver of fibrin accumulation. When you are under chronic psychological stress, your body produces more cortisol, the primary stress hormone. Cortisol has a direct and well-documented effect on the clotting system: it increases the production of procoagulant factors in the liver and enhances platelet clumping, while simultaneously inhibiting fibrinolysis by decreasing t-PA production and increasing PAI-1.17PubMed Central. Stress-induced hemostasis: mechanisms and implications for health In plain terms, chronic stress makes your blood more prone to clotting and less able to dissolve those clots.
This creates a double problem for anyone trying to reduce fibrin naturally. On one side, stress pushes your body to produce more fibrinogen. On the other, it suppresses the enzymes that break fibrin down. Stress-reduction techniques like meditation, deep breathing, adequate sleep, and even spending time in nature are not just vaguely beneficial. They address a specific hormonal pathway that directly shifts the clotting-versus-dissolving balance. If you are supplementing with nattokinase or exercising regularly but living in a state of constant cortisol elevation, you are fighting an upstream problem with downstream tools.
How to Know if You Have Too Much Fibrin
Most people exploring this topic have some reason to suspect excess fibrin or a hypercoagulable state. A standard blood test can measure fibrinogen levels directly. Normal plasma fibrinogen typically ranges from about 200 to 400 mg/dL, though labs vary slightly. For reference, one study comparing different metabolic groups found that people with normal blood sugar had fibrinogen levels around 216 mg/dL, those with impaired fasting glucose averaged 348 mg/dL, and people with type 2 diabetes averaged 449 mg/dL.18PubMed. Levels of plasma fibrinogen and d-dimer in patients with impaired fasting glucose Blood sugar problems and fibrin buildup often travel together.
D-dimer is another commonly ordered test. It measures fragments left behind when fibrin is broken down, so elevated D-dimer indicates that clots are both forming and being dissolved somewhere in the body. D-dimer is sensitive but not very specific: it goes up with infection, surgery, pregnancy, cancer, and many other conditions. Combining D-dimer with fibrinogen levels improves the diagnostic picture. Research has found that the ratio of D-dimer to fibrinogen can be more useful for predicting venous blood clots than either marker alone, especially in older adults.19PubMed Central. D-Dimer Combined with Fibrinogen Predicts the Risk of Venous Thrombosis in Fracture Patients If you are working with a doctor on this, asking for both markers gives a more complete view than either one in isolation.
Microclots and Long COVID
Interest in clearing fibrin naturally surged during and after the COVID-19 pandemic, and for good reason. Researchers discovered that fibrinogen can clot into an unusual “amyloid” form of fibrin that resists normal breakdown by plasmin. These amyloid fibrin microclots are tiny, persistent, and can trap inflammatory proteins inside them.20PubMed Central. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications In people with Long COVID, these microclots have been found in high concentrations in plasma and are thought to block capillaries, reducing oxygen delivery to tissues and potentially explaining symptoms like fatigue, brain fog, and exercise intolerance.21PubMed Central. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC)
The challenge with amyloid microclots is that they are structurally different from normal fibrin clots. Because they fold into a beta-sheet-rich configuration (similar to the misfolded proteins seen in Alzheimer’s disease), they are partially resistant to the normal enzymatic processes that clear regular fibrin.22PubMed Central. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system This is why some Long COVID patients report limited benefit from standard natural fibrinolytic strategies alone. Preliminary clinical reports have explored “triple anticoagulant” protocols combining prescription blood thinners and antiplatelet agents, but these are experimental and carry significant bleeding risk. Whether natural fibrinolytic enzymes like nattokinase can address amyloid-form fibrin specifically is an active area of interest but not yet answered by controlled trials.
Microclots are not unique to Long COVID. Research in critically ill patients with sepsis has found that pathogen-related molecules and acute-phase proteins can alter fibrinogen structure in ways that promote similar aggregate formation.23PubMed Central. Microclots, as defined by amyloid-fibrinogen aggregates, predict risks of disseminated intravascular coagulation and mortality This suggests that the problem of treatment-resistant fibrin may be broader than any single disease.
When Natural Approaches Can Be Dangerous
Fibrin is not the enemy. It is what keeps you from bleeding out when you nick yourself shaving. Clearing too much of it, or interfering with clotting at the wrong time, creates real danger. Anyone taking prescription anticoagulants like warfarin, heparin, or direct oral anticoagulants (apixaban, rivarelbaan) should be extremely cautious about adding fibrinolytic supplements. Nattokinase, serrapeptase, lumbrokinase, and bromelain all have some degree of blood-thinning or anticoagulant activity, and stacking them with prescription medications can push bleeding risk to hazardous levels.
The case of the patient who substituted nattokinase for warfarin after a mechanical valve replacement illustrates the ceiling of these supplements clearly.5PubMed Central. Consequence of patient substitution of nattokinase for warfarin after aortic valve replacement with a mechanical prosthesis That patient developed a life-threatening clot within a year. Natural fibrinolytic enzymes may support the body’s clot-clearing processes in people with mildly elevated fibrinogen or a general interest in cardiovascular health, but they are not potent or predictable enough to replace medications where high-stakes anticoagulation is required.
People scheduled for surgery should also stop fibrinolytic supplements at least two weeks beforehand, as the combination of surgical tissue damage and impaired clotting ability can lead to excessive bleeding. And anyone with a bleeding disorder, active ulcers, or a history of hemorrhagic stroke should avoid these supplements entirely unless specifically cleared by a physician.
Putting It All Together Without Overdoing It
If your fibrinogen levels are mildly elevated or you are interested in supporting healthy fibrin turnover, a reasonable approach combines several of the strategies above rather than relying on a single one. Regular aerobic exercise increases your body’s own t-PA output. Omega-3 fatty acids from fish or supplements gently lower fibrinogen through a mechanism that does not interfere with vitamin K pathways. Managing chronic stress removes one of the most powerful brakes on your fibrinolytic system. And a well-chosen fibrinolytic enzyme supplement can add direct fibrin-dissolving activity on top of those foundational steps.
The order matters. Exercise and stress reduction are free, carry minimal risk, and address the root physiology. Dietary changes like increasing omega-3 intake come next. Supplemental enzymes are reasonable to add once the lifestyle foundation is in place, but they work best as an addition rather than a substitute. Monitor your progress with periodic fibrinogen and D-dimer testing if your doctor is willing to order them, and never swap out a prescribed blood thinner for any supplement on your own. The body’s fibrinolytic system is remarkably capable when it is given the conditions to function well. Most of the work is about removing the obstacles: sedentary behavior, chronically high cortisol, inflammatory diets, and poor sleep.